NM_001378615.1:c.4597_4598delCT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378615.1(CC2D2A):c.4597_4598delCT(p.Leu1533ValfsTer12) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,176 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L1533L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378615.1 frameshift
Scores
Clinical Significance
Conservation
Publications
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Joubert syndrome 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- retinitis pigmentosa 93Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- COACH syndrome 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndrome with oculorenal defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CC2D2A | NM_001378615.1 | c.4597_4598delCT | p.Leu1533ValfsTer12 | frameshift_variant | Exon 36 of 37 | ENST00000424120.6 | NP_001365544.1 | |
| CC2D2A | NM_001080522.2 | c.4597_4598delCT | p.Leu1533ValfsTer12 | frameshift_variant | Exon 37 of 38 | NP_001073991.2 | ||
| CC2D2A | NM_001378617.1 | c.4450_4451delCT | p.Leu1484ValfsTer12 | frameshift_variant | Exon 34 of 35 | NP_001365546.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152102Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 248894 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461074Hom.: 0 AF XY: 0.00000550 AC XY: 4AN XY: 726824 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74298 show subpopulations
ClinVar
Submissions by phenotype
Joubert syndrome 1 Pathogenic:1
- -
Meckel-Gruber syndrome;C0431399:Joubert syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Leu1533Valfs*12) in the CC2D2A gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 88 amino acid(s) of the CC2D2A protein. This variant is present in population databases (rs794729226, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with CC2D2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 242584). This variant disrupts a region of the CC2D2A protein in which other variant(s) (p.Asp1556Val) have been determined to be pathogenic (PMID: 19777577, 22241855, 22425360, 23012439, 26092869, 26477546). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at